Large-scale testing (Phase 3)Study completedNCT00116688
What this trial is testing
Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Who this might be right for
ThrombocytopeniaIdiopathic Thrombocytopenic Purpura
Amgen 313